Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingchang Yuyang Decoction is a **traditional Chinese medicine (TCM) herbal formula** utilized for the management of ulcerative colitis (UC). It is composed of a mixture of multiple Chinese medicinal herbs, often including *Huangqin* (Scutellaria baicalensis), *Baitouweng* (Pulsatilla chinensis), *Tufuling* (Smilax glabra), *Baishao* (Paeonia lactiflora), *Diyu* (Sanguisorba officinalis), *Qiancao* (Rubia cordifolia), *Xuchangqing* (Cynanchum paniculatum), *Baizhi* (Angelica dahurica), and *Gancao* (Glycyrrhiza uralensis) blended in specific proportions. The decoction is traditionally prepared by boiling these herbs in water and concentrating the extract[2]. The main therapeutic benefit is **amelioration of ulcerative colitis** symptoms: reducing inflammation, enhancing mucosal barrier function, adjusting intestinal flora, and improving colonic energy metabolism. Modern studies suggest its action involves activation of the **peroxisome proliferator-activated receptor gamma (PPAR-γ)**, influencing mitochondrial TCA cycle activity, leading to decreased expansion of pathogenic facultative anaerobes such as certain pathogenic *Escherichia coli*. Notable representative constituents include baicalin, paeoniflorin, mollugin, and imperatorin, shown to interact with PPAR-γ[1][2]. Clinical studies indicate that, when used in combination with standard therapies such as mesalazine, the decoction further improves clinical outcomes, inflammatory markers, and composition of gut flora, reducing harmful *Enterococcus* and *Enterobacter* while increasing beneficial bacteria like *Bifidobacterium*, *Butyric Clostridium*, and *Lactobacillus*[3][5][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingchang Yuyang Decoction.